Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Qa-1 restriction of CD8+ suppressor T cells.

Sarantopoulos S, Lu L, Cantor H.

J Clin Invest. 2004 Nov;114(9):1218-21. Review.

2.

Analysis of regulatory CD8 T cells in Qa-1-deficient mice.

Hu D, Ikizawa K, Lu L, Sanchirico ME, Shinohara ML, Cantor H.

Nat Immunol. 2004 May;5(5):516-23. Epub 2004 Apr 18.

PMID:
15098030
3.
4.

Regulation of CD8+ regulatory T cells: Interruption of the NKG2A-Qa-1 interaction allows robust suppressive activity and resolution of autoimmune disease.

Lu L, Kim HJ, Werneck MB, Cantor H.

Proc Natl Acad Sci U S A. 2008 Dec 9;105(49):19420-5. doi: 10.1073/pnas.0810383105. Epub 2008 Dec 1.

5.

Physiological induction of regulatory Qa-1-restricted CD8+ T cells triggered by endogenous CD4+ T cell responses.

Varthaman A, Clement M, Khallou-Laschet J, Fornasa G, Gaston AT, Dussiot M, Caligiuri G, Cantor H, Kaveri S, Nicoletti A.

PLoS One. 2011;6(6):e21628. doi: 10.1371/journal.pone.0021628. Epub 2011 Jun 27.

6.

HLA-E-restricted regulatory CD8(+) T cells are involved in development and control of human autoimmune type 1 diabetes.

Jiang H, Canfield SM, Gallagher MP, Jiang HH, Jiang Y, Zheng Z, Chess L.

J Clin Invest. 2010 Oct;120(10):3641-50. doi: 10.1172/JCI43522. Epub 2010 Sep 27.

7.

The immunoregulatory effects of Qa-1.

Lu L, Werneck MB, Cantor H.

Immunol Rev. 2006 Aug;212:51-9. Review.

PMID:
16903905
8.

Comeback kids: CD8(+) suppressor T cells are back in the game.

Van Kaer L.

J Clin Invest. 2010 Oct;120(10):3432-4. doi: 10.1172/JCI44395. Epub 2010 Sep 27.

9.

Suppression of autoimmune disease after vaccination with autoreactive T cells that express Qa-1 peptide complexes.

Panoutsakopoulou V, Huster KM, McCarty N, Feinberg E, Wang R, Wucherpfennig KW, Cantor H.

J Clin Invest. 2004 Apr;113(8):1218-24.

11.

Regulation of self-tolerance by Qa-1-restricted CD8(+) regulatory T cells.

Kim HJ, Cantor H.

Semin Immunol. 2011 Dec;23(6):446-52. doi: 10.1016/j.smim.2011.06.001. Review.

12.

The non-classical MHC class I molecule Qa-1(b) inhibits classical MHC class I-restricted cytotoxicity of cytotoxic T lymphocytes.

Lohwasser S, Kubota A, Salcedo M, Lian RH, Takei F.

Int Immunol. 2001 Mar;13(3):321-7.

PMID:
11222501
13.

Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.

Filaci G, Fravega M, Negrini S, Procopio F, Fenoglio D, Rizzi M, Brenci S, Contini P, Olive D, Ghio M, Setti M, Accolla RS, Puppo F, Indiveri F.

Hum Immunol. 2004 Feb;65(2):142-56.

PMID:
14969769
14.
15.

Generation and regulation of CD8(+) regulatory T cells.

Lu L, Cantor H.

Cell Mol Immunol. 2008 Dec;5(6):401-6. doi: 10.1038/cmi.2008.50. Review.

16.

Amelioration of arthritis through mobilization of peptide-specific CD8+ regulatory T cells.

Leavenworth JW, Tang X, Kim HJ, Wang X, Cantor H.

J Clin Invest. 2013 Mar;123(3):1382-9. doi: 10.1172/JCI66938. Epub 2013 Feb 8.

17.

Induction of TCR Vbeta-specific CD8+ CTLs by TCR Vbeta-derived peptides bound to HLA-E.

Li J, Goldstein I, Glickman-Nir E, Jiang H, Chess L.

J Immunol. 2001 Oct 1;167(7):3800-8.

18.

T cell vaccination induces T cell receptor Vbeta-specific Qa-1-restricted regulatory CD8(+) T cells.

Jiang H, Kashleva H, Xu LX, Forman J, Flaherty L, Pernis B, Braunstein NS, Chess L.

Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4533-7.

19.

Implication for the CD94/NKG2A-Qa-1 system in the generation and function of ocular-induced splenic CD8+ regulatory T cells.

Chattopadhyay S, O'Rourke J, Cone RE.

Int Immunol. 2008 Apr;20(4):509-16. doi: 10.1093/intimm/dxn008.

PMID:
18359787
20.

Glatiramer acetate ameliorates inflammatory bowel disease in mice through the induction of Qa-1-restricted CD8⁺ regulatory cells.

Yao Y, Han W, Liang J, Ji J, Wang J, Cantor H, Lu L.

Eur J Immunol. 2013 Jan;43(1):125-36. doi: 10.1002/eji.201242758. Epub 2012 Nov 7.

Supplemental Content

Support Center